Colombian and German flags intertwined with DNA and neurons, symbolizing Alzheimer's research collaboration.

Unlocking Alzheimer's: How a Colombian-German Network is Pioneering Research

Lena Kashyap monogram
Lena Kashyap in Health & Wellness October 2026 • 4 min read.

"Discover how the UndoAD project is bridging continents to combat neurodegenerative diseases through innovative research and international collaboration."


In an era where global collaboration faces increasing challenges, the international scientific community recognizes that progress is heavily dependent on cooperation across borders. This is especially critical in translational research, where diverse expertise and comprehensive patient cohort assessments are essential.

This article sheds light on UndoAD, a groundbreaking initiative that aims to raise awareness within the South American neurological community. By focusing on hereditary neurological diseases, particularly in the mountainous region surrounding Medellín, Colombia, UndoAD leverages unique resources to combat Alzheimer's disease.

Medellín, Colombia, is home to numerous families affected by hereditary neurological diseases. Over the past three decades, researchers have identified disease-associated mutations, established unique clinical cohorts, and created a clinical registry with thousands of patient records. These efforts have also led to the establishment of a brain bank, which now includes donations from over 300 individuals.

AI Search Multiple angles on this topic

Current Impact

Alzheimer's disease is a major health and wellness concern affecting individuals, families, and communities. Its impact includes progressive cognitive decline and substantial caregiving needs. The scale and specific statistics are not detailed in the available source material.

Current Approaches

Alzheimer's care generally combines clinical assessment, symptom management, supportive services, and ongoing research. These approaches may help address aspects of the disease but do not eliminate its underlying progression. The available source material does not provide details about specific methods or their limitations.

Historical Foundations

Research into Alzheimer's has developed over time through advances in medical observation, neuroscience, and clinical investigation. These developments have gradually improved understanding of the disease and shaped modern research priorities. No specific historical milestones or foundational discoveries are identified in the available source material.

The Power of Collaboration: Uncovering Alzheimer's Mechanisms

Colombian and German flags intertwined with DNA and neurons, symbolizing Alzheimer's research collaboration.

UndoAD focuses on a rare form of familial Alzheimer's disease caused by an autosomal dominant presenilin mutation. This patient population is invaluable for clinical research, exemplified by an ongoing key prevention trial involving an international research team from the USA and Colombia. This trial is testing crenezumab, an investigational drug, to delay the onset of the disease in carriers of presenilin mutations (NCT01998841).

Another fruitful collaboration has developed between Colombian and German institutions to understand the mechanisms of neurodegeneration. By studying brains collected from a cohort of presenilin mutation carriers, this collaboration has already provided critical insights into the pathophysiology of familial Alzheimer's disease. The UndoAD project aims to pinpoint the molecular mechanisms underlying the heterogeneity observed in the clinical presentations of patients from the Colombian familial Alzheimer's disease cohort.

  • Scientific Exchange: UndoAD facilitates the exchange of scientific knowledge, promoting collaborative research environments.
  • Knowledge Transfer: By transferring expertise and innovative techniques, UndoAD strengthens research capabilities.
  • Infrastructure Development: Investments in infrastructure ensure long-term advancements in neurological research.
  • Summer Schools: UndoAD sponsors summer schools in Medellín, Colombia, offering comprehensive lectures and workshops. The first of these took place on September 12-13, 2018.
AI Search Multiple angles on this topic

Recent Research

Current Alzheimer's research spans disease mechanisms, diagnosis, treatment, and prevention. Researchers continue to investigate approaches that could improve outcomes and clarify how the disease progresses. The available source material does not identify particular recent studies, reviews, or findings.

Research Challenges

Alzheimer's research has faced uncertainty, incomplete explanations, and approaches that have not produced definitive solutions. These difficulties underscore the complexity of translating scientific findings into effective care. The available source material does not document specific failed studies or competing arguments.

Comparing Approaches

Comparing Alzheimer's research strategies can help distinguish differences in goals, evidence, and practical application. Such comparisons may clarify which approaches focus on diagnosis, treatment, prevention, or caregiving. The available source material does not supply the studies or figures needed for a detailed comparison.

In addition to unraveling the complexities of Alzheimer's, UndoAD aims to foster further international collaborations. The project plans to organize meetings focused on brain banking, inviting scientists from other brain banks in Latin America to participate. The goal is to encourage sample exchange, standardize protocols, and improve data management to broaden neuropathological research in Latin America.

Building a Future of Collaborative Research

The German Federal Ministry of Education and Research supports the UndoAD project, as part of their initiative to promote research structures in Latin America. The goal is to build long-term collaborations with research institutions in partner countries, ensuring that the fight against neurodegenerative diseases is a global effort.

AI Search Multiple angles on this topic

Overall Synthesis

Alzheimer's research requires coordination among scientific disciplines, healthcare providers, patients, and families. A cautious synthesis recognizes both meaningful progress and continuing uncertainty. No expert commentary is included in the available source material.

Evidence and Uncertainty

The supplied sources discuss Yahoo Mail rather than Alzheimer's research or future medical frontiers. One Reddit discussion reports that email may be routed to Yahoo Mail's trash through filters or applications such as Outlook or Mac Mail. Other supplied discussions mention Yahoo Mail pricing and service-access problems, but they provide no evidence about Alzheimer's research, emerging treatments, or future directions.

Systemic Considerations

Alzheimer's affects more than individual patients; it also places demands on families, healthcare systems, research institutions, and public policy. Progress therefore depends on both scientific discovery and the ability to deliver effective, equitable support. The available source material does not provide specific evidence about these systemic challenges.

People and Care

The human consequences of Alzheimer's include changes in memory, independence, relationships, and daily caregiving responsibilities. Patient and caregiver experiences are important for evaluating whether research translates into meaningful improvements in life. The available source material does not include specific patient or caregiver accounts.

What plasma p-tau231 adds to the picture

The age-related difference suggests plasma p-tau231 may reflect disease-related changes before the kindred’s typical age of mild cognitive impairment onset. It does not establish that the marker predicts when any individual will develop symptoms.[1]

The findings support investigating this blood measure for tracking Alzheimer’s pathology and evaluating disease-modifying therapies, but they describe potential uses rather than proving clinical benefit.[1]

How the Colombian findings compare

Brain-tissue work compared the morphology and distribution of amyloid-beta species in PS1 E280A familial Alzheimer’s cases with sporadic Alzheimer’s tissue. The reported high variability in plaque size and distribution across groups and regions limits how simply those patterns can be summarized.[2]

The registry’s large carrier count does not by itself ensure that people enrolled in a particular prevention trial represent the wider at-risk population. A separate baseline note also allows that subtle changes near clinical onset might not be apparent on formal assessment.[3]

What remains unresolved about these findings

  • Can variation in plaque size and distribution help explain differences in clinical presentation, or does the reported variability make that relationship difficult to resolve?[2]
  • How might subtle changes near clinical onset affect the interpretation of baseline assessments when they are not fully evident in clinical or objective testing?[3]

Sources

  1. Plasma p‐tau231 in the presenilin 1 E280A autosomal dominant Alzheimer’s disease kindred: a cross‐sectional and longitudinal cohort study (pmc.ncbi.nlm.nih.gov)
  2. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer’s Disease Patients (www.frontiersin.org)
  3. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the UndoAD project?

The UndoAD project is a collaborative initiative between Colombian and German scientists dedicated to combating Alzheimer's disease. It leverages unique patient cohorts and advanced research methods, focusing on hereditary neurological diseases, particularly in the mountainous region surrounding Medellín, Colombia. The project aims to raise awareness within the South American neurological community and foster international collaborations to further the understanding of Alzheimer's and develop effective treatments.

2

How does the UndoAD project utilize the resources available in Medellín, Colombia?

UndoAD capitalizes on the unique resources in Medellín, including families affected by hereditary neurological diseases. Over the past three decades, researchers have identified disease-associated mutations, established unique clinical cohorts, and created a clinical registry with thousands of patient records. Additionally, the project benefits from a brain bank with donations from over 300 individuals, providing invaluable resources for studying the mechanisms of Alzheimer's disease.

3

What specific research areas does UndoAD focus on?

UndoAD focuses on a rare form of familial Alzheimer's disease caused by an autosomal dominant presenilin mutation. This patient population is crucial for clinical research, including a key prevention trial testing crenezumab, an investigational drug, to delay the onset of the disease in carriers of presenilin mutations. The project also studies the mechanisms of neurodegeneration by studying brains collected from a cohort of presenilin mutation carriers to pinpoint the molecular mechanisms underlying the heterogeneity observed in the clinical presentations of patients from the Colombian familial Alzheimer's disease cohort.

4

What are the key components of the UndoAD project's international collaboration?

UndoAD's international collaboration involves several key components. It facilitates scientific exchange, promotes collaborative research environments, and supports knowledge transfer by transferring expertise and innovative techniques to strengthen research capabilities. Infrastructure development is another key focus, ensuring long-term advancements in neurological research. Furthermore, the project sponsors summer schools in Medellín, Colombia, providing comprehensive lectures and workshops. The project also plans to organize meetings focused on brain banking, inviting scientists from other brain banks in Latin America to encourage sample exchange, standardize protocols, and improve data management.

5

How is the UndoAD project supported, and what are its long-term goals?

The UndoAD project is supported by the German Federal Ministry of Education and Research as part of an initiative to promote research structures in Latin America. The long-term goals include building long-term collaborations with research institutions in partner countries to ensure that the fight against neurodegenerative diseases is a global effort. The project aims to not only unravel the complexities of Alzheimer's but also to foster further international collaborations, particularly in the area of brain banking, to broaden neuropathological research in Latin America.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.